1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-ol;2-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-3-ylethanol;1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyridin-3-ylpropan-2-ol;10-(2-pyridin-3-ylethyl)-6,10,12-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraene

C84H94N14O3 — CID 161064433

IUPAC1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-ol;2-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-3-ylethanol;1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyridin-3-ylpropan-2-ol;10-(2-pyridin-3-ylethyl)-6,10,12-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraene
SMILESCC(O)(Cn1c2c(c3ccccc31)C1CCCN1CC2)c1cccnc1.CC(O)(Cn1c2c(c3ccccc31)C1CCCN1CC2)c1cnccn1.OC(Cn1c2c(c3ccccc31)C1CCCN1CC2)c1cccnc1.c1cncc(CCn2c3c(c4cccnc42)C2CCCN2CC3)c1
InChIInChI=1S/C22H25N3O.C21H24N4O.C21H23N3O.C20H22N4/c1-22(26,16-6-4-11-23-14-16)15-25-18-8-3-2-7-17(18)21-19-9-5-12-24(19)13-10-20(21)25;1-21(26,19-13-22-9-10-23-19)14-25-16-6-3-2-5-15(16)20-17-7-4-11-24(17)12-8-18(20)25;25-20(15-5-3-10-22-13-15)14-24-17-7-2-1-6-16(17)21-18-8-4-11-23(18)12-9-19(21)24;1-4-15(14-21-9-1)7-13-24-18-8-12-23-11-3-6-17(23)19(18)16-5-2-10-22-20(16)24/h2-4,6-8,11,14,19,26H,5,9-10,12-13,15H2,1H3;2-3,5-6,9-10,13,17,26H,4,7-8,11-12,14H2,1H3;1-3,5-7,10,13,18,20,25H,4,8-9,11-12,14H2;1-2,4-5,9-10,14,17H,3,6-8,11-13H2
InChIKeyUDVCISSFNDSKRD-UHFFFAOYSA-N
MW1347.77 g/mol
LogP13.50
Rot. Bonds12

About 1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-ol;2-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-3-ylethanol;1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyridin-3-ylpropan-2-ol;10-(2-pyridin-3-ylethyl)-6,10,12-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraene

1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-ol;2-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-3-ylethanol;1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyridin-3-ylpropan-2-ol;10-(2-pyridin-3-ylethyl)-6,10,12-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraene (PubChem CID 161064433) has the molecular formula C84H94N14O3 and a molecular weight of 1347.77 g/mol. Its IUPAC name is 1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-ol;2-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-3-ylethanol;1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyridin-3-ylpropan-2-ol;10-(2-pyridin-3-ylethyl)-6,10,12-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraene.

Molecular Properties

Compound Name1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-ol;2-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-3-ylethanol;1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyridin-3-ylpropan-2-ol;10-(2-pyridin-3-ylethyl)-6,10,12-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraene
PubChem CID161064433
Molecular FormulaC84H94N14O3
Molecular Weight1347.77 g/mol
Exact Mass1346.76
IUPAC Name1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-ol;2-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-3-ylethanol;1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyridin-3-ylpropan-2-ol;10-(2-pyridin-3-ylethyl)-6,10,12-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraene
SMILESCC(O)(Cn1c2c(c3ccccc31)C1CCCN1CC2)c1cccnc1.CC(O)(Cn1c2c(c3ccccc31)C1CCCN1CC2)c1cnccn1.OC(Cn1c2c(c3ccccc31)C1CCCN1CC2)c1cccnc1.c1cncc(CCn2c3c(c4cccnc42)C2CCCN2CC3)c1
InChIInChI=1S/C22H25N3O.C21H24N4O.C21H23N3O.C20H22N4/c1-22(26,16-6-4-11-23-14-16)15-25-18-8-3-2-7-17(18)21-19-9-5-12-24(19)13-10-20(21)25;1-21(26,19-13-22-9-10-23-19)14-25-16-6-3-2-5-15(16)20-17-7-4-11-24(17)12-8-18(20)25;25-20(15-5-3-10-22-13-15)14-24-17-7-2-1-6-16(17)21-18-8-4-11-23(18)12-9-19(21)24;1-4-15(14-21-9-1)7-13-24-18-8-12-23-11-3-6-17(23)19(18)16-5-2-10-22-20(16)24/h2-4,6-8,11,14,19,26H,5,9-10,12-13,15H2,1H3;2-3,5-6,9-10,13,17,26H,4,7-8,11-12,14H2,1H3;1-3,5-7,10,13,18,20,25H,4,8-9,11-12,14H2;1-2,4-5,9-10,14,17H,3,6-8,11-13H2
InChIKeyUDVCISSFNDSKRD-UHFFFAOYSA-N
XLogP13.50
TPSA170.71 Ų
H-Bond Donors3
H-Bond Acceptors17
Rotatable Bonds12
Heavy Atoms101
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001347.77
LogP ≤ 513.50
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'indol_3yl_alk(461)', 'substructure': 'N/A'}

Analyze 1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-ol;2-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-3-ylethanol;1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyridin-3-ylpropan-2-ol;10-(2-pyridin-3-ylethyl)-6,10,12-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-(4-Fluorophenyl)-2-[2-[4-[3-[[4-[3-[[4-[4-[4-[5-[1-(4-fluorophenyl)-1-hydroxyethyl]pyrimidin-2-yl]-3-methylpiperazin-1-yl]pyrrolo[2,1-f][1,2,4]triazin-6-yl]pyrazol-1-yl]methyl]-4-[4-[5-[2-(4-fluorophenyl)-1-hydroxypropan-2-yl]pyrimidin-2-yl]piperazin-1-yl]pyrrolo[2,1-f][1,2,4]triazin-3-ium-6-yl]pyrazol-1-yl]methyl]-6-(1-methylpyrazol-4-yl)pyrrolo[2,1-f][1,2,4]triazin-3-ium-4-yl]piperazin-1-yl]pyrimidin-5-yl]propan-1-ol
CID 123217151
2-(8-chloro-2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5-yl)-1-[4-(trifluoromethyl)phenyl]ethanol;8-[2-[6-(1,1-difluoroethyl)-3-pyridinyl]ethyl]-4,12-dimethyl-3,8,12-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),3,5-tetraene;8-[2-[6-(1,1-difluoroethyl)-3-pyridinyl]ethyl]-4,12-dimethyl-4,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),10,12-tetraene;8-[2-[6-(1,1-difluoroethyl)-3-pyridinyl]ethyl]-4,12-dimethyl-4,8,11-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),10,12-tetraene
CID 157268350
1-(2-hydroxy-2,8-dimethyl-3,4-dihydro-1H-pyrido[4,3-b]indol-2-ium-5-yl)-2-pyridin-3-ylpropan-2-ol;1-[8-(hydroxymethyl)-2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5-yl]-2-pyridin-3-ylpropan-2-ol;1-[6-(hydroxymethyl)-1,2,3,4-tetrahydrocarbazol-9-yl]-2-pyridin-3-ylpropan-2-ol;4-methyl-8-[2-[6-(trifluoromethyl)-3-pyridinyl]ethyl]-4,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),10,12-tetraene
CID 158385621
12-Chloro-4-methyl-8-[2-(6-methyl-3-pyridinyl)ethyl]-4,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),10,12-tetraene;12-chloro-4-methyl-8-[2-[6-(trifluoromethyl)-3-pyridinyl]ethyl]-4,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),10,12-tetraene;1-(8,10-dimethyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyridin-4-ylpropan-2-ol;1-(10-methyl-1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyridin-4-ylpropan-2-ol
CID 158588182
N-[5-[(1S)-1-(4-ethylpiperazin-1-yl)-3,3,3-trifluoropropyl]-2-pyridinyl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine;N-[5-[(1R)-1-(4-ethylpiperazin-1-yl)-3,3,3-trifluoropropyl]-2-pyridinyl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine;[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]-(1-methylpiperidin-4-yl)methanol;[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]-piperidin-4-ylmethanol;(R)-[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]-piperidin-4-ylmethanol;(S)-[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]-piperidin-4-ylmethanol
CID 159034809
7-[2-(3-Cyclopropylphenyl)-3-pyridinyl]imidazo[1,5-a]pyridine;1-[6-[2-(4-fluoro-3-methylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]ethanol;2-[6-[2-(4-fluoro-3-methylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]propan-2-ol;7-[2-(3-methylphenyl)-3-pyridinyl]imidazo[1,5-a]pyridine;6-[2-[3-(trideuteriomethyl)phenyl]-3-pyridinyl]imidazo[1,2-a]pyridine;7-[2-[3-(trifluoromethyl)phenyl]-3-pyridinyl]imidazo[1,5-a]pyridine
CID 159236919
(S)-(1-ethylpiperidin-4-yl)-[6-[[5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-yl]amino]-3-pyridinyl]methanol;N-[5-[(1R)-1-(1-ethylpiperidin-4-yl)propyl]-2-pyridinyl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine;N-[5-[(1S)-1-(1-ethylpiperidin-4-yl)propyl]-2-pyridinyl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine;N-[5-[1-(1-ethylpiperidin-4-yl)propyl]-2-pyridinyl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine;N-[5-[(1R)-1-(1-ethylpiperidin-4-yl)-2,2,2-trifluoroethyl]-2-pyridinyl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine;N-[5-[1-(1-ethylpiperidin-4-yl)-2,2,2-trifluoroethyl]-2-pyridinyl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine
CID 159289266
1-[1-[(2,2-Dimethyl-1,3-dioxolan-4-yl)methyl]indol-3-yl]-2,2,2-trifluoro-1-[3-(4-fluorophenyl)imidazo[1,5-a]pyridin-7-yl]ethanol;3-[3-[2,2,2-trifluoro-1-[3-(4-fluorophenyl)imidazo[1,5-a]pyridin-7-yl]-1-hydroxyethyl]indol-1-yl]propane-1,2-diol
CID 159422257
4-[[6-[2-(3-Cyclopropylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[[6-[2-(4-fluoro-3-methylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;4-[[6-[2-(3-methylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]methyl]morpholine;[6-[2-[3-(trifluoromethyl)phenyl]-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]methanol;4-[[6-[2-[3-(trifluoromethyl)phenyl]-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]methyl]morpholine
CID 159948651
[6-[2-(3-Cyclopropylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]methanol;6-[2-(3-cyclopropylphenyl)-3-pyridinyl]-3-pyrrolidin-1-ylimidazo[1,2-a]pyridine;[6-[2-(4-fluoro-3-methylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]methanol;[6-[2-(3-methylphenyl)-3-pyridinyl]imidazo[1,2-a]pyridin-3-yl]methanol;6-[2-(3-methylphenyl)-3-pyridinyl]-3-pyrrolidin-1-ylimidazo[1,2-a]pyridine;3-pyrrolidin-1-yl-6-[2-[3-(trifluoromethyl)phenyl]-3-pyridinyl]imidazo[1,2-a]pyridine
CID 160218243
2-[(2R,6S)-1-ethyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-5-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]imidazo[1,2-a]pyridine;3-fluoro-2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-5-(4-methylpiperazin-1-yl)imidazo[1,2-a]pyridine;[2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-5-[4-(2,2,2-trifluoroethyl)piperazin-1-yl]imidazo[1,2-a]pyridin-3-yl]methanol;2-[(2R,6S)-1-methyl-6-(3-methyl-2-pyridinyl)piperidin-2-yl]-3-[[1-(2,2,2-trifluoroethyl)piperidin-4-yl]methyl]imidazo[1,2-a]pyridine
CID 160615097
2-(4,12-dimethyl-4,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),10,12-tetraen-8-yl)-1-(6-methyl-3-pyridinyl)ethanol;1-(4,12-dimethyl-4,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),10,12-tetraen-8-yl)-2-pyridin-3-ylpropan-2-ol;1-[8-(hydroxymethyl)-2-methyl-3,4-dihydro-1H-pyrido[4,3-b]indol-5-yl]-2-pyridin-3-ylpropan-2-ol;4-methyl-8-[2-[6-(trifluoromethyl)-3-pyridinyl]ethyl]-4,8,10-triazatricyclo[7.4.0.02,7]trideca-1(9),2(7),10,12-tetraene
CID 160866795

Frequently Asked Questions

What is the IUPAC name of 1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-ol;2-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-3-ylethanol;1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyridin-3-ylpropan-2-ol;10-(2-pyridin-3-ylethyl)-6,10,12-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraene?
The IUPAC name of 1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-ol;2-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-3-ylethanol;1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyridin-3-ylpropan-2-ol;10-(2-pyridin-3-ylethyl)-6,10,12-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraene (CID 161064433) is 1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-ol;2-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-3-ylethanol;1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyridin-3-ylpropan-2-ol;10-(2-pyridin-3-ylethyl)-6,10,12-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraene.
What is the SMILES notation for 1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-ol;2-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-3-ylethanol;1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyridin-3-ylpropan-2-ol;10-(2-pyridin-3-ylethyl)-6,10,12-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraene?
The canonical SMILES for 1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-ol;2-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-3-ylethanol;1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyridin-3-ylpropan-2-ol;10-(2-pyridin-3-ylethyl)-6,10,12-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraene is CC(O)(Cn1c2c(c3ccccc31)C1CCCN1CC2)c1cccnc1.CC(O)(Cn1c2c(c3ccccc31)C1CCCN1CC2)c1cnccn1.OC(Cn1c2c(c3ccccc31)C1CCCN1CC2)c1cccnc1.c1cncc(CCn2c3c(c4cccnc42)C2CCCN2CC3)c1.
What is the InChIKey of 1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-ol;2-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-3-ylethanol;1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyridin-3-ylpropan-2-ol;10-(2-pyridin-3-ylethyl)-6,10,12-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraene?
The InChIKey is UDVCISSFNDSKRD-UHFFFAOYSA-N. The full InChI is InChI=1S/C22H25N3O.C21H24N4O.C21H23N3O.C20H22N4/c1-22(26,16-6-4-11-23-14-16)15-25-18-8-3-2-7-17(18)21-19-9-5-12-24(19)13-10-20(21)25;1-21(26,19-13-22-9-10-23-19)14-25-16-6-3-2-5-15(16)20-17-7-4-11-24(17)12-8-18(20)25;25-20(15-5-3-10-22-13-15)14-24-17-7-2-1-6-16(17)21-18-8-4-11-23(18)12-9-19(21)24;1-4-15(14-21-9-1)7-13-24-18-8-12-23-11-3-6-17(23)19(18)16-5-2-10-22-20(16)24/h2-4,6-8,11,14,19,26H,5,9-10,12-13,15H2,1H3;2-3,5-6,9-10,13,17,26H,4,7-8,11-12,14H2,1H3;1-3,5-7,10,13,18,20,25H,4,8-9,11-12,14H2;1-2,4-5,9-10,14,17H,3,6-8,11-13H2.
What are the key properties of 1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-ol;2-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-3-ylethanol;1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyridin-3-ylpropan-2-ol;10-(2-pyridin-3-ylethyl)-6,10,12-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraene?
1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-ol;2-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-3-ylethanol;1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyridin-3-ylpropan-2-ol;10-(2-pyridin-3-ylethyl)-6,10,12-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraene has a molecular weight of 1347.77 g/mol, XLogP of 13.50, 12 rotatable bonds, 3 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for 1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyrazin-2-ylpropan-2-ol;2-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-1-pyridin-3-ylethanol;1-(1,2,3,5,6,11c-hexahydroindolizino[7,8-b]indol-7-yl)-2-pyridin-3-ylpropan-2-ol;10-(2-pyridin-3-ylethyl)-6,10,12-triazatetracyclo[7.7.0.02,6.011,16]hexadeca-1(9),11(16),12,14-tetraene is sourced from PubChem (CID 161064433), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).